Epigenetic mutagenesis as program of age-related protein dysfunction and aging

被引:0
|
作者
G. A. Romanov
V. S. Sukhoverov
B. F. Vanyushin
机构
[1] Moscow State University,Belozersky Institute of Physicochemical Biology
[2] Russian Academy of Sciences,Timiryazev Institute of Plant Physiology
[3] Russian Academy of Sciences,Trapeznikov Institute of Control Sciences
关键词
gene; protein; epigenetic mutagenesis; methylation; deamination; genome; mutation; CpG-site;
D O I
暂无
中图分类号
学科分类号
摘要
DNA methylation plays an important polyfunctional role in ontogenesis of human and mammals. A steep rise in probability of mutational substitution of CpG dinucleotide by TpG dinucleotide in the genome is one of the consequences of DNA methylation. All spectrum (17) of possible DNA and protein mutations caused by CpG-dinucleotide methylation in DNA were characterized, and the three most dangerous mutations able to result in protein inactivation were isolated. The computer program that allows one to predict all most probable mutations in the analyzed gene and encoded protein was created. On the example of genes from humans and various mammals, it was demonstrated that the amount of potentially dangerous sites of epigenetic mutagenesis in exons was drastically decreased as a result of genome evolution. But, at the same time, unforced preservation of such sites and their persistence were established, indicating the occurrence of age-related protein dysfunction built into the genome epigenetic program, resulting in apoptosis and aging; this program is based on the set and position of methylated codons in exonic gene regions. It is assumed that the program of epigenetic mutagenesis limits the lifetime of an individual, accelerating the deliverance of the population from long-lived individuals that completed the reproductive period.
引用
收藏
页码:78 / 87
页数:9
相关论文
共 50 条
  • [31] Aging, frailty and age-related diseases
    T. Fulop
    A. Larbi
    J. M. Witkowski
    J. McElhaney
    M. Loeb
    A. Mitnitski
    G. Pawelec
    Biogerontology, 2010, 11 : 547 - 563
  • [32] iPSCs, aging and age-related diseases
    Isobe, Ken-ichi
    Cheng, Zhao
    Nishio, Naomi
    Suganya, Thanasegan
    Tanaka, Yuriko
    Ito, Sachiko
    NEW BIOTECHNOLOGY, 2014, 31 (05) : 411 - 421
  • [33] Sirtuins in aging and age-related disease
    Longo, Valter D.
    Kennedy, Brian K.
    CELL, 2006, 126 (02) : 257 - 268
  • [34] Epigenetics,aging and age-related disorders
    Perez, R. F.
    Tejedor, J.
    Santamarina, P.
    Fernandez, A. F.
    Fraga, M. F.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2019, 27 : 765 - 766
  • [35] Inflammation in Aging and Age-related Disease
    Ikeno, Yuji
    Orihuela, Carlos
    Van Remmen, Holly
    PATHOBIOLOGY OF AGING AND AGE-RELATED DISEASES, 2011, 1 (01):
  • [36] Stresses, Aging, and Age-Related Disorders
    Li, Xiaotao
    Moses, Robb E.
    Jin, Jianping
    Cao, Weiguo
    Caulin, Carlos
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2014, 2014
  • [37] Aging, frailty and age-related diseases
    Fulop, T.
    Larbi, A.
    Witkowski, J. M.
    McElhaney, J.
    Loeb, M.
    Mitnitski, A.
    Pawelec, G.
    BIOGERONTOLOGY, 2010, 11 (05) : 547 - 563
  • [38] Telomere, aging and age-related diseases
    Huanjiu Xi
    Changyong Li
    Fu Ren
    Hailong Zhang
    Luping Zhang
    Aging Clinical and Experimental Research, 2013, 25 : 139 - 146
  • [39] β cell aging and age-related diabetes
    Zhu, Min
    Liu, Xiaohong
    Liu, Wen
    Lu, Yanrong
    Cheng, Jingqiu
    Chen, Younan
    AGING-US, 2021, 13 (05): : 7691 - 7706
  • [40] Epigenetics in aging and age-related diseases
    Santa-Cruz Calvo, Sara
    Navas, Placido
    Lopez-Lluch, Guillermo
    APPROACHES TO AGING CONTROL, 2010, (14): : 68 - 74